Immune Cell Resident Gene RBPJ Emerges as Key to Lung Cancer Immunotherapy Success
A new single-cell study identifies the transcription factor RBPJ and CD103-positive tissue-resident memory T cells as central drivers of successful ...
A new single-cell study identifies the transcription factor RBPJ and CD103-positive tissue-resident memory T cells as central drivers of successful ...
A new review argues that the ketogenic diet may act as a systems-level sensitization platform in cancer therapy by simultaneously ...
Researchers have introduced the Spatial Immune Barrier Index, a spatial transcriptomics measure that quantifies the suppressive barrier holding immune cells ...
A new review details how hydrogel-based 3D platforms are transforming cancer research by recreating the tumor microenvironment for drug testing, ...
A stage-spanning single-cell atlas of bladder cancer identifies a CXCR4-positive vascular-immune barrier at the T1 stage that excludes T cells ...
A new review in Cancer Cell International explains how metabolic reprogramming in colorectal cancer tumors suppresses anti-tumor immunity and how ...
Researchers developed a random forest model integrating six clinical, inflammatory and molecular predictors that forecasts immunotherapy response in advanced lung ...
A phase 2 trial found that the HDAC inhibitor entinostat combined with nivolumab produced no tumor responses in advanced cholangiocarcinoma, ...
Researchers at Sun Yat-Sen University have developed a three-gene signature based on platinum resistance biology that predicts overall survival and ...
New research identifies the enzyme CYP2S1 as a driver of immunosuppressive cell recruitment and poor chemoimmunotherapy response in esophageal squamous ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine